Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.54%
EBIT Growth (5y)
6.72%
EBIT to Interest (avg)
90.72
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.09
Sales to Capital Employed (avg)
1.10
Tax Ratio
23.35%
Dividend Payout Ratio
38.13%
Pledged Shares
17.94%
Institutional Holding
26.64%
ROCE (avg)
29.63%
ROE (avg)
22.14%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
36
Industry P/E
34
Price to Book Value
8.44
EV to EBIT
30.96
EV to EBITDA
27.12
EV to Capital Employed
9.18
EV to Sales
6.94
PEG Ratio
2.46
Dividend Yield
0.92%
ROCE (Latest)
29.63%
ROE (Latest)
23.33%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend5What is working for the Company
NET SALES(Q)
Highest at Rs 1,421.64 cr
-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)
Lowest at 2.94 times
Loading Valuation Snapshot...
Here's what is working for Ajanta Pharma
Net Sales - Quarterly
Highest at Rs 1,421.64 cr and Grown
each quarter in the last five quartersMOJO Watch
Near term sales trend is very positive
Net Sales (Rs Cr)
Net Sales - Quarterly
At Rs 1,421.64 cr has Grown at 21.47%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (Rs Cr)
Here's what is not working for Ajanta Pharma
Debtors Turnover Ratio- Half Yearly
Lowest at 2.94 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
Non Operating Income - Quarterly
Highest at Rs 61.43 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
